Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at lenvatinib for people with neuroendocrine tumours that have spread (TALENT)

Overview

Cancer types:

Neuroendocrine tumour (NET)

Status:

Results

Phase:

Phase 2

Details

This trial was for people with a neuroendocrine tumour that had started in the pancreas, stomach or bowel.

This trial was open for people to join between October 2016 and September 2017.

Recruitment start: 3 October 2016

Recruitment end: 30 September 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Juan Valle

Supported by

Grupo Español de Tumores Neuroendrocrinos (GETNE)

The Christie NHS Foundation Trust

Last reviewed: 12 Dec 2019

CRUK internal database number: 14978

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.